3 C) and plasma osteopontin showed a trend toward reduction in the clodronate-treated group compared with the HFHC diet-fed control (Fig. 3 D).
← all excerpts
Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury.
1
—
—